MedPath

Disclosure Intervention for People in Treatment for Opioid Use Disorder

Not Applicable
Recruiting
Conditions
Opioid Use Disorder
Registration Number
NCT06458985
Lead Sponsor
University of Delaware
Brief Summary

The goal of this clinical trial is to test a disclosure intervention among people in treatment for opioid use disorder. The main question it aims to answer is whether people who receive a disclosure intervention have better treatment- and recovery-related outcomes one year after receiving the intervention. Participants will complete a brief disclosure intervention designed to help them (1) make key disclosures related to disclosure and (2) build skills to disclose. Researchers will compare results to participants in a waitlist comparator condition, who receive the intervention at the end of the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
480
Inclusion Criteria
  • Client of Brandywine Counseling & Community Services
  • Receiving opioid use disorder treatment at Brandywine Counseling & Community Services
  • Considering disclosing one's opioid use disorder history and/or treatment to someone new
Exclusion Criteria
  • Diagnosis of schizophrenia
  • Participation in pilot study of intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Illicit opioid use1 year

Percentages of drug screens that are positive for illicit opioid use

Retention in treatment1 year

Whether participants are retained in treatment 1 year after baseline

Secondary Outcome Measures
NameTimeMethod
Recovery capital score1 year

Average scores on recovery capital measure (titled: Brief Assessment of Recovery Capital); items are measured on a 1-5 point Likert-type scale, and composite scores range from 1-5. Higher values indicate greater recovery capital.

Quality of life score1 year

Average scores on quality of life measure (titled: European Health Interview Survey-Quality of Life - 8 item); items are measured on a 1-5 point Likert-type scale, and composite scores range from 1-5. Higher scores indicate greater quality of life.

Trial Locations

Locations (1)

Brandywine Counseling & Community Services

🇺🇸

Wilmington, Delaware, United States

Brandywine Counseling & Community Services
🇺🇸Wilmington, Delaware, United States
Carly Hill
Contact
1-302-401-1397‬
UDiscloseResearch@gmail.com
© Copyright 2025. All Rights Reserved by MedPath